Skip to main content
. Author manuscript; available in PMC: 2013 Apr 19.
Published in final edited form as: Int J Androl. 2012 Feb 9;35(4):616–625. doi: 10.1111/j.1365-2605.2011.01245.x

Table 3.

Age-standardized incidence rates (cases per 1 million) of gonadal and extragonadal germ cell tumors by primary site, sex and race; SEER-9, 1973–2007

Topography (ICD-O) Males
Females
White Black White Black
N ASR SE N ASR SE N ASR SE N ASR SE

Gonadal germ cell tumors
Testis (C62.0–C62.9) 19,517 56.3 0.41 442 10.0 0.49
Ovary (C56) 1,095 3.2 0.10 175 1.9 0.1
Primary sites of extragonadal germ cell tumors
Thymus (C37.9) 18 0.1 0.01 0 2 0
Mediastinum (C38.1–C38.3) 406 1.2 0.06 25 0.5 0.11 38 0.1 0.02 3
Retroperitoneum (C48.0) 154 0.5 0.04 7 13 6
Pelvis (C49.5, C76.3) 39 0.1 0.02 4 60 0.2 0.02 18 0.3 0.17
Uterus (C54–C55) 46 0.1 0.02 23 0.3 0.09
Female genital tract (C57) 23 0.1 0.01 2
Placenta (C58) 312 0.9 0.05 92 1.7 0.17
Brain, NOS (C71.0–C71.9) 83 0.2 0.03 8 41 0.1 0.02 11
Pineal gland (C75.3) 175 0.5 0.04 23 0.4 0.09 10 0
Pituitary gland (C75.1) 20 0.1 0.01 0 16 0.0 0.01 1
Malignant neoplasm of other and ill-defined sites (C76excl. C76.3) 8 1 2 0
Other sites* 60 0.2 0.02 9 52 0.2 0.02 19 0.4 0.09
Unknown primary site (C80.9) 162 0.5 0.04 9 27 0.1 0.02 7
All extragonadal germ cell tumors 1,125 3.3 0.10 86 1.8 0.20 641 1.9 0.07 182 3.4 0.25
*

all other sites had less than 16 registered cases in each sex-race stratum of the registration period 1973–2007; ASR: age-standardized rate; SE: standard error of ASR